Beijing Beilu Pharmaceutical Co., Ltd (SHE:300016)

SHE:300016 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	544.72	257.46	748.45	766.73	895.02	1,014
Trading Asset Securities	289.65	350.77	-	-	-	-
Cash & Short-Term Investments	834.37	608.23	748.45	766.73	895.02	1,014
Cash Growth	4.01%	-18.73%	-2.38%	-14.33%	-11.71%	308.10%
Accounts Receivable	170.32	176.36	188.55	112.67	142.52	190.37
Other Receivables	0.57	9.54	5.87	8.39	5.81	15.36
Receivables	170.88	185.9	194.42	121.06	148.33	205.73
Inventory	354.59	362.09	244.86	276.22	250.01	117.12
Other Current Assets	47.54	14.95	9.07	14	12.72	14.48
Total Current Assets	1,407	1,171	1,197	1,178	1,306	1,351
Property, Plant & Equipment	971.78	976.03	876.23	840.46	795.3	739.48
Long-Term Investments	196.1	536.76	556.06	561.19	553.2	508.43
Goodwill	46.92	46.92	-	31.82	51.23	51.23
Other Intangible Assets	157.61	160.82	128.39	125.1	138.99	138.04
Long-Term Accounts Receivable	1.26	1.43	-	-	-	-
Long-Term Deferred Tax Assets	37.07	41.33	41.38	39.32	18.15	11.07
Long-Term Deferred Charges	22.48	24.94	17.2	36.95	32.4	36.17
Other Long-Term Assets	366.27	18.11	3.38	5.83	8.92	12.1
Total Assets	3,207	2,978	2,819	2,819	2,904	2,848
Accounts Payable	147.86	171.32	115.12	140.9	141.13	137.03
Accrued Expenses	14.33	44.5	34.89	32.05	26.06	24.12
Short-Term Debt	215.12	140.02	175.56	107.61	79.08	143.91
Current Portion of Long-Term Debt	112.52	49	12.4	10.09	20.13	6
Current Portion of Leases	-	3.26	3.04	2.74	0.27	-
Current Income Taxes Payable	10.03	-	-	-	0.01	0.01
Current Unearned Revenue	6.06	8.76	2.01	4.45	3.8	7.95
Other Current Liabilities	55.95	38.38	16.14	4.83	15.09	24.54
Total Current Liabilities	561.87	455.23	359.17	302.67	285.56	343.54
Long-Term Debt	704.88	600.24	592.55	516.28	476.1	553.18
Long-Term Leases	0.25	4.8	7.17	9.98	0.14	-
Long-Term Unearned Revenue	27.26	16.84	11.74	7.89	10.45	13.76
Long-Term Deferred Tax Liabilities	68.32	70.93	62.48	58.56	45.98	45.01
Total Liabilities	1,363	1,148	1,033	895.39	818.22	955.5
Common Stock	491.95	491.95	491.93	491.96	492.72	494.49
Additional Paid-In Capital	135.34	135.34	135.22	135.3	201.27	188.53
Retained Earnings	940.98	926.45	912.79	1,019	1,042	945.96
Treasury Stock	-	-	-	-0.1	-9.06	-18.01
Comprehensive Income & Other	115.03	113.86	110.67	130.27	130.04	130.93
Total Common Equity	1,683	1,668	1,651	1,776	1,857	1,742
Minority Interest	161	161.9	135.69	146.88	229.03	150.17
Shareholders' Equity	1,844	1,829	1,786	1,923	2,086	1,892
Total Liabilities & Equity	3,207	2,978	2,819	2,819	2,904	2,848
Total Debt	1,033	797.32	790.72	646.71	575.72	703.09
Net Cash (Debt)	-198.4	-189.09	-42.28	120.03	319.31	310.64
Net Cash Growth	-	-	-	-62.41%	2.79%	25.05%
Net Cash Per Share	-0.44	-0.42	-0.09	0.21	0.66	0.64
Filing Date Shares Outstanding	491.95	491.95	491.93	491.96	492.72	494.49
Total Common Shares Outstanding	491.95	491.95	491.93	491.96	492.72	494.49
Working Capital	845.51	715.95	837.62	875.34	1,021	1,008
Book Value Per Share	3.42	3.39	3.36	3.61	3.77	3.52
Tangible Book Value	1,479	1,460	1,522	1,619	1,667	1,553
Tangible Book Value Per Share	3.01	2.97	3.09	3.29	3.38	3.14
Buildings	-	700.49	561.7	557.21	532.04	503.45
Machinery	-	567.37	503.01	470.31	400.02	288.48
Construction In Progress	-	70.26	110.39	44.99	49	87.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.